Astrazeneca Plc Stock Today
| AZNCF Stock | USD 125.50 0.80 0.64% |
Performance0 of 100
| Odds Of DistressLess than 12
|
AstraZeneca PLC is trading at 125.50 as of the 21st of November 2024. This is a 0.64 percent increase since the beginning of the trading day. The stock's lowest day price was 125.5. AstraZeneca PLC has less than a 12 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for AstraZeneca PLC are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 22nd of October 2024 and ending today, the 21st of November 2024. Click here to learn more.
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom. Astrazeneca Plc operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. The company has 1.55 B outstanding shares. More on AstraZeneca PLC
Moving together with AstraZeneca Pink Sheet
| 0.89 | LLY | Eli Lilly | PairCorr |
| 0.81 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
| 0.89 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.83 | RHHBY | Roche Holding | PairCorr |
| 0.87 | RHHVF | Roche Holding AG | PairCorr |
Moving against AstraZeneca Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
AstraZeneca Pink Sheet Highlights
| President | Pam Cheng |
| Business Concentration | Drug Manufacturers—General, Healthcare (View all Sectors) |
AstraZeneca PLC [AZNCF] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Mega-Cap' category with a current market capitalization of 215.86 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AstraZeneca PLC's market, we take the total number of its shares issued and multiply it by AstraZeneca PLC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. AstraZeneca PLC classifies itself under Healthcare sector and is part of Drug Manufacturers—General industry. The entity has 1.55 B outstanding shares.
AstraZeneca PLC has accumulated about 4.89 B in cash with 9.81 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.15.
Check AstraZeneca PLC Probability Of Bankruptcy
Ownership AllocationAstraZeneca PLC holds a total of 1.55 Billion outstanding shares. 30% of AstraZeneca PLC outstanding shares are owned by other corporate entities. Institutional investors are typically referred to investors that purchase positions in a given stock to benefit from reduced commissions. Consequently, institutional investors are subject to different rules and regulations than regular investors. Please look out for any change in current institutional holding as this could mean something significant has changed at the company or is about to change. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check AstraZeneca Ownership Details
AstraZeneca PLC Risk Profiles
| Mean Deviation | 1.64 | |||
| Standard Deviation | 2.21 | |||
| Variance | 4.9 | |||
| Risk Adjusted Performance | (0.14) |
AstraZeneca Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in AstraZeneca PLC without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Stocks Directory Now
Stocks DirectoryFind actively traded stocks across global markets |
| All Next | Launch Module |
AstraZeneca PLC Corporate Management
| Chris Sheldon | Head Relations | Profile | |
| MBA DVM | CEO Director | Profile | |
| Gonzalo Vina | Head Relations | Profile | |
| Aradhana MD | CFO Director | Profile |
Other Information on Investing in AstraZeneca Pink Sheet
AstraZeneca PLC financial ratios help investors to determine whether AstraZeneca Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in AstraZeneca with respect to the benefits of owning AstraZeneca PLC security.